NCT01549847

A Randomized, Double Blind, Placebo Controlled Trial L-carnitine and Piracetam in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome

A Phase III, Randomized, Double Blind, Placebo Controlled Trial to Evaluate the Therapeutic Effect of the Association of L-carnitine and Piracetam as an Adjuvant Therapy in the Treatment of Weakness, Muscle Fatigue and Muscle Pain in the Postpoliomyelitis Syndrome

• Status: Withdrawn
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Biolab Sanus Farmaceutica · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

This protocol aims to assess of L-carnitine and piracetam to relieve weakness, muscle fatigue and muscle pain in patients with Postpoliomyelitis Syndrome.

Conditions

• Postpoliomyelitis Syndrome

Interventions

Type	Name	Description
DRUG	L-carnitine and piracetam	L-carnitine/piracetam (990mg/810mg) PO BID
DRUG	Placebo	Placebo PO BID

Timeline

• Primary completion: 2013-02-01
• First posted: 2012-03-09
• Last updated: 2015-11-17

Locations

1 site across 1 country: Brazil